Tweet
<img alt="" height="1" width="1" />
Sanofi shares drop on cancer drug setback
Reuters
PARIS (Reuters) - Shares in French drugmaker Sanofi-Aventis (SASY.PA), which is trying to buy US biotech group Genzyme (GENZ.O), fell 5 percent on Friday after a setback to a cancer drug seen worth some $800 million as of 2015. ...
Sanofi Suffers Cancer-Drug SetbackWall Street Journal
Sanofi-Aventis cancer drug trials disappointFinancial Times
Sanofi-Aventis says cancer drug has little effectBloomberg
RTT News -TheStreet.com -Malaysia Sun
all 49 news articles »
More...